Company Monitoring Page for JNJ

latest headlines for company on cafepharma

Johnson & Johnson, AbbVie superstar Imbruvica flunks pancreatic cancer test
Fierce Pharma
Mon, 01/21/19 - 10:54 am
Tags:
AbbVie, JNJ, Imbruvica, pancreatic cancer, clinical trials
Johnson & Johnson Is Trying to Recover From Plunge
Investopedia
Fri, 01/18/19 - 10:13 am
Tags:
JNJ, earnings
Apple and Johnson & Johnson collaborating on heart research project
Marketwatch
Thu, 01/17/19 - 09:36 am
Tags:
Apple, JNJ, Janssen, atrial fibrillation, Apple Watch, wearables, devices
European Commission Approves Janssen's Erleada for Patients at High Risk of Developing Metastatic Prostate Cancer
CP Wire
Wed, 01/16/19 - 10:03 am
Tags:
Janssen, JNJ, Erleada, prostate cancer, Europe
Wed, 01/16/19 - 09:52 am
Tags:
Janssen, JNJ, Erleada, prostate cancer
J&J hikes US prices for a basket of drugs, including certain top-sellers
Endpoints
Fri, 01/11/19 - 09:55 am
Tags:
JNJ, drug pricing
JP Morgan's Dimon hosted a private dinner for pharma executives, and a major topic was Amazon
CNBC
Thu, 01/10/19 - 09:50 am
Tags:
JNJ, Pfizer, Eli Lilly, Jamie Dimon, Amazon, JPMHC 2019
J&J still sees plenty of opportunity in crowded immunology markets—starting with psoriasis
Fierce Pharma
Wed, 01/9/19 - 12:56 pm
Tags:
JNJ, JPMHC 2019, immunology, psoriasis, Tremfya
Andexxa will go nationwide with FDA nod on Portola's commercial production of the bleeding antidote
Fierce Pharma
Wed, 01/2/19 - 11:38 am
Tags:
Portola Pharmaceuticals, AndexXa, Pfizer, Bristol-Myers Squibb, JNJ, Bayer, FDA, anticoagulant reversal
Down but Not Out: 10 Biggest Drug Trials That Saw Challenges in 2018
BioSpace
Fri, 12/21/18 - 12:10 pm
Tags:
clinical trials, Takeda, Zinfandel Pharmaceuticals, pioglitazone, Alzheimer's disease, Boehringer Ingelheim, BI 409306, Merck, verubecestat, Celgene, MS, ozanimod, Incyte, ID01, melanoma, vTv Therapeutics, azeliragon, Roche, Tecentriq, Exelixis, colorectal cancer, JNJ, atabacestat, Sareptat Therapeutics, DMD, Exondys 51, Alkermes, ALKS-5461, clinical depression
Judge refuses to overturn $4.7 billion talc powder verdict
Yahoo/AP
Thu, 12/20/18 - 11:47 pm
Tags:
JNJ, ovarian cancer
Johnson & Johnson tries to win back trust from investors with 5-billion-dollar share repurchase program
GoinPharma
Thu, 12/20/18 - 12:15 am
Tags:
JNJ, share repurchase
J&J hits back over asbestos in talc claims
Pharmaforum
Mon, 12/17/18 - 08:59 am
Tags:
JNJ, asbestos
J&J stock tumbles after Reuters reports it hid asbestos in talc
Fierce Pharma
Fri, 12/14/18 - 12:41 pm
Tags:
JNJ
Report: J&J willing to pay more than $400m to settle Pinnacle hip cases
Mass Device
Thu, 12/13/18 - 10:30 am
Tags:
JNJ, devices, Pinnacle Hip
J&J chief figures Amazon could shake up pharma's distribution, rebates and more
Fierce Pharma
Tue, 12/11/18 - 11:47 am
Tags:
Amazon, JNJ, Pharma CEOs, Alex Gorsky, distribution, drug rebates
Lessons From The Biggest Pharma Drug Launches Of All Time
Forbes
Tue, 12/11/18 - 10:26 am
Tags:
drug launches, Gilead Sciences, JNJ, Pfizer
ASH successes set to lift Imbruvica in CLL
Biopharma Dive
Thu, 12/6/18 - 07:01 pm
Tags:
AbbVie, Imbruvica, CLL, JNJ, ASH 2018
Actelion inks $360M deal to resolve DOJ kickbacks probe
Fierce Pharma
Thu, 12/6/18 - 06:54 pm
Tags:
JNJ, DOJ, PAH, Actelion, kickbacks
ASH: J&J's fast-growing Darzalex lines up for second front-line myeloma OK
Fierce Pharma
Tue, 12/4/18 - 11:33 am
Tags:
JNJ, Darzalex, Multiple Myeloma, ASH 2018

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.